Strategic Alliance Partnership Program
RDR has partnered with leading medical institutions and advocacy groups to provide our audience with the latest in clinical research and advocacy innovation.
MOST POPULAR ARTICLES
FDA Approves Hydroxyurea Tablets for Pediatric Sickle Cell Anemia
Q&A with Hartmann Wellhoefer, Shire's VP and Head of Medical Affairs; Rare Diseases & Internal Medicine
HDSA Partners with ALS Association and Teva for CNS Disorder Research
IND Application for Scleroderma Drug Greenlighted by FDA
STRATEGIC ALLIANCE PARTNERSHIP PROGRAM >
Familial Chylomicronemia Syndrome
MJH ASSOCIATES >
Specialty Pharmacy Times
Terms & Conditions
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.